✦ LIBER ✦

Stage distribution in patients with a small (≤ 3 cm) primary nonsmall cell lung carcinoma : Implication for lung carcinoma screening

✍ Scribed by Laura E. Heyneman; James E. Herndon; Philip C. Goodman; Edward F. Patz Jr.

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 162 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011215)92:12<3051::aid-cncr10106>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radiotherapy for patients with medically

Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma : Smaller volumes and higher doses-A review

✍ Gregory S. Sibley 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## Background: Surgical resection remains the treatment of choice for patients with stage i nonsmall cell lung carcinoma. however, there is a group of patients who are medically inoperable and are treated with radiotherapy alone. this review summarizes findings from published series of radiotherapy

Utility of screening procedures for dete

Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma

✍ Edith A. Perez; Charles L. Loprinzi; Jeff A. Sloan; David T. Owens; Paul J. Novo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views

## Background: Studies evaluating the efficacy of routine follow-up testing in detecting disease recurrence in treated lung carcinoma patients are lacking. ## Methods: To investigate this subject, the authors studied 115 patients who had previously been entered on north central cancer treatment g

Pilot study of accelerated hyperfraction

Pilot study of accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage III non-small cell lung carcinoma

✍ Jeffrey S. Brindle; Edward G. Shaw; John Q. Su; James A. Mailliard; Albert R. Fr 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

Induction chemotherapy employing dose-in

Induction chemotherapy employing dose-intense cisplatin with mitomycin and vinblastine (MVP400), followed by thoracic surgery or irradiation, for patients with stage III nonsmall cell lung carcinoma

✍ Kenneth K. Ng; Mark G. Kris; Robert J. Ginsberg; Robert T. Heelan; Katherine M. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. Cisplatin-based induction chemotherapy before surgery or irradiation has improved the survival of patients with Stage III nonsmall cell lung carcinoma (NSCLC). Encouraged by earlier results with preoperative MVP (cisplatin [120 mg/m 2 or 25 mg/m 2 /week], vinblastine, and mitomycin)

Prognostic factors for patients with sma

Prognostic factors for patients with small cell lung carcinoma : Analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years

✍ M. Paesmans.; J. P. Sculier; J. Lecomte; J. Thiriaux; P. Libert; R. Sergysels; G 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

A Phase II study of all-trans-retinoic a

A Phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma : An Eastern Cooperative Oncology Group study

✍ Gregory P. Kalemkerian; Michael Jiroutek; David S. Ettinger; John A. Dorighi; Da 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Cancer Institute.